Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Caribou Biosciences (CRBU) Other Operating Expenses (2025)

Caribou Biosciences has reported Other Operating Expenses over the past 1 years, most recently at $12.1 million for Q2 2025.

  • Quarterly Other Operating Expenses changed N/A to $12.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $12.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $12.1 million for FY2025, N/A changed from the prior year.
  • Other Operating Expenses was $12.1 million for Q2 2025 at Caribou Biosciences.
  • Over five years, Other Operating Expenses peaked at $12.1 million in Q2 2025 and troughed at $12.1 million in Q2 2025.